Scientific Publications Search Search Author Release Date Research Group Search Sort by RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Order AscDesc Blankenstein, Thomas Prof. Dr. (16) Daniel, Peter Prof. Dr. (1) Jarosch, Ernst Dr. (5) Kammertöns, Thomas Dr. (5) Kettenmann, Helmut Prof. Dr. (31) Krabbe, Grietje Dr. (1) Ku, Min-Chi Dr. (2) Leisegang, Matthias Prof. Dr. rer. nat. (1) Maglione, Marta (1) Nolte, Christiane Dr. (6) Pezzutto, Antonio Prof. Dr. (2) Quensel, Christina Dr. (1) Selbach, Matthias Prof. Dr. (1) Semtner, Marcus Dr. (1) Siffrin, Volker (1) Sommer, Thomas Prof. Dr. (11) Willimsky, Gerald Dr. (1) Wolf, Susanne Dr. (5) (-) Kopp, Joachim Dr. (1) (-) Nguyen, Tam Hoai Dr. (1) (-) Uckert, Wolfgang Prof. Dr. (5) 2002 (2) 2003 (4) (-) 2004 (3) 2005 (5) 2006 (1) 2007 (2) 2008 (2) 2010 (2) (-) 2011 (4) 2013 (1) (-) 2014 (1) 2015 (3) 2016 (3) 2017 (2) 2018 (3) (-) Cellular Neurosciences (1) Epigenetic Regulation and Chromatin Architecture (9) From Cell States to Function (1) (-) Intracellular Proteolysis (1) Molecular Cardiovascular Research (1) (-) Molecular Immunology and Gene Therapy (6) Pancreatic Organoid Research and Disease Modeling (1) Proteome Dynamics (1) RNA Biology and Posttranscriptional Regulation (1) Systems Biology of Gene Regulatory Elements (3) Translational Oncology of Solid Tumors (1) 8 Results: Active Filter: Kopp, Joachim Dr.Nguyen, Tam Hoai Dr.Uckert, Wolfgang Prof. Dr.Cellular NeurosciencesIntracellular ProteolysisMolecular Immunology and Gene Therapy200420112014 Sort: Result score Newest to oldest Oldest to newest January 01, 2004 / Gene Ther Flt-3 ligand as adjuvant for DNA vaccination augments immune responses but does not skew TH1/TH2 polarization J. Westermann T. Nguyen-Hoai A. Mollweide G. Richter O. Schmetzer H.J. Kim T. Blankenstein B. Doerken A. Pezzutto July 01, 2004 / Eur J Immunol Dual T cell receptor T cells with two defined specificities mediate tumor suppression via both receptors M. Gladow W. Uckert T. Blankenstein January 15, 2011 / Int J Cancer Tumor rejection by local interferon gamma induction in established tumors is associated with blood vessel destruction and necrosis D. Briesemeister D. Sommermeyer C. Loddenkemper R. Loew W. Uckert T. Blankenstein T. Kammertoens April 01, 2011 / Gene Ther Allogeneic gene-modified tumor cells (RCC-26/IL-7/CD80) as a vaccine in patients with metastatic renal cell cancer: a clinical phase-I study J. Westermann A. Floercken G. Willimsky A. van Lessen J. Kopp A. Takvorian K. Joehrens A. Lukowsky C. Schoenemann B. Sawitzki H. Pohla R. Frank B. Doerken D.J. Schendel T. Blankenstein A. Pezzutto January 01, 2004 / Mol Cell Vpu-mediated degradation of CD4 reconstituted in yeast reveals mechanistic differences to cellular ER-associated protein degradation B. Meusser T. Sommer June 01, 2011 / Cell Calcium Transmitter- and hormone-activated Ca(2+) responses in adult microglia/brain macrophages in situ recorded after viral transduction of a recombinant Ca(2+) sensor S. Seifert M. Pannell W. Uckert K. Faerber H. Kettenmann July 28, 2011 / Blood The only proposed T-cell epitope derived from the TEL-AML1 translocation is not naturally processed J. Popovic L.P. Li P.M. Kloetzel M. Leisegang W. Uckert T. Blankenstein September 01, 2014 / Eur J Immunol Misinitiation of intrathymic MART-1 transcription and biased TCR usage explain the high frequency of MART-1-specific T cells S. Pinto D. Sommermeyer C. Michel S. Wilde D. Schendel W. Uckert T. Blankenstein B. Kyewski
January 01, 2004 / Gene Ther Flt-3 ligand as adjuvant for DNA vaccination augments immune responses but does not skew TH1/TH2 polarization J. Westermann T. Nguyen-Hoai A. Mollweide G. Richter O. Schmetzer H.J. Kim T. Blankenstein B. Doerken A. Pezzutto
July 01, 2004 / Eur J Immunol Dual T cell receptor T cells with two defined specificities mediate tumor suppression via both receptors M. Gladow W. Uckert T. Blankenstein
January 15, 2011 / Int J Cancer Tumor rejection by local interferon gamma induction in established tumors is associated with blood vessel destruction and necrosis D. Briesemeister D. Sommermeyer C. Loddenkemper R. Loew W. Uckert T. Blankenstein T. Kammertoens
April 01, 2011 / Gene Ther Allogeneic gene-modified tumor cells (RCC-26/IL-7/CD80) as a vaccine in patients with metastatic renal cell cancer: a clinical phase-I study J. Westermann A. Floercken G. Willimsky A. van Lessen J. Kopp A. Takvorian K. Joehrens A. Lukowsky C. Schoenemann B. Sawitzki H. Pohla R. Frank B. Doerken D.J. Schendel T. Blankenstein A. Pezzutto
January 01, 2004 / Mol Cell Vpu-mediated degradation of CD4 reconstituted in yeast reveals mechanistic differences to cellular ER-associated protein degradation B. Meusser T. Sommer
June 01, 2011 / Cell Calcium Transmitter- and hormone-activated Ca(2+) responses in adult microglia/brain macrophages in situ recorded after viral transduction of a recombinant Ca(2+) sensor S. Seifert M. Pannell W. Uckert K. Faerber H. Kettenmann
July 28, 2011 / Blood The only proposed T-cell epitope derived from the TEL-AML1 translocation is not naturally processed J. Popovic L.P. Li P.M. Kloetzel M. Leisegang W. Uckert T. Blankenstein
September 01, 2014 / Eur J Immunol Misinitiation of intrathymic MART-1 transcription and biased TCR usage explain the high frequency of MART-1-specific T cells S. Pinto D. Sommermeyer C. Michel S. Wilde D. Schendel W. Uckert T. Blankenstein B. Kyewski